Navigation Links
InVitria Presents Zap-CHO Performance Results at PEACe Conference
Date:9/23/2009

Zap-CHO: a new and innovative CHO cell culture supplement from InVitria designed to deliver superior growth, maximum antibody productivity and faster cell line development. Performance results were presented to attendees of the PEACe Conference in Jackson Hole, WY this week.

Fort Collins, CO September 23, 2009 / b3c newswire / C A new powerful and robust cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO was featured this week at the 9th Protein Expression in Animal Cells (PEACe) Conference in Jackson Hole, Wyoming.
Zap-CHO is a significant breakthrough in mammalian cell culture systems, said Dr. Steve Pettit, InVitrias Director of Cell Culture Development. With the development of Zap-CHO, InVitria has created a performance enhancing CHO media supplement that is the first animal free supplement capable of replacing fetal bovine serum (FBS) without sacrificing performance and maintaining a well defined media. Since Zap-CHO is a defined and animal component-free product, it is well suited for commercial, chemically-defined and serum- and animal-free cell culture media formulations, said Dr. Pettit.
Dr. Pettit presented the Zap-CHO performance results during the technical workshop and he also presented during the poster session at PEACe on Tuesday. Copies of the poster and presentation are available by contacting InVitria at the email address or phone number listed below.
Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Previously, only FBS could deliver equivalent performance, but safety concerns of a fetal bovine component in cell culture media forced many customers away from this component. In the last decade, customers have eliminated FBS in cell culture media only to lose cell culture performance. To regain the lost performance, many began adding hydrolysates to the media. However, hydrolysa
'/>"/>

b3c newswire

Page: 1 2

Related biology news :

1. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
2. InVitria Sponsors ESACT 2009 in Dublin, Ireland
3. InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO
4. InVitria Announces Launch of Recombinant Albumin for Diagnostics
5. The BBVA Foundation presents its Frontiers of Knowledge Awards
6. Versartis presents positive preclinical data on 2 product candidates at ENDO 09
7. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
8. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
9. GSA special paper presents new studies of Western US earth motion
10. AIUM Presents 2009 Joseph H. Holmes Pioneer Awards
11. AIUM presents 2009 Memorial Hall of Fame awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Boulder, Colo., USA A new GSA Bulletin ... along the lower Rio Puerco and Chaco Wash in ... tree rings from salt cedar and willow, investigators were ... thick or greater. They then combined this data with ... reconstruct the history of these arroyos. , Arroyos are ...
(Date:9/18/2014)... from McGill University and the Quebec government have ... Canadian Journal of Fisheries and Aquatic Sciences ... household cleansers, or industrial cleansers, to which they ... small size and buoyancy, they may readily pass ... global contaminant in the world,s oceans, but have ...
(Date:9/18/2014)... is stored in DNA, tiny strands of nucleic acid ... To express this genetic data, our DNA is copied ... proteins that perform tasks in our cells. , ... RNA molecule. Unlike all other known RNAs, this molecule ... molecules are abundant, little has been known about how ...
Breaking Biology News(10 mins):Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Microplastic pollution discovered in St. Lawrence River sediments 2Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2
(Date:9/19/2014)... 19, 2014 BioTech News Coverage: ... and results of studies and trials.  Companies in focus ... (NYSE: LLY ), Gilead Sciences Inc. (NASDAQ: ... CELG ) and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) ... prodrug therapeutics for the treatment of cancer, announced that ...
(Date:9/19/2014)... September 19, 2014 The new , ... , available today on PharmaBoardroom.com for ... crisis that rocked the Spanish economy in 2009, and the ... community has remained pragmatic in times of trouble. ... the fifth biggest European market, and the general conditions to ...
(Date:9/18/2014)... A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... 2014 Research and Markets has ... Stem Cell Industry Report, 2014-2017" report to their ... cells that can differentiate into specialized cells and can ... cell therapy can be applied to treatment of cardiovascular ... system diseases, damage or lesion of liver, kidney and ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... Expedite the Drug Discovery Process , ... , , ... ... VANCOUVER , March ...
... understand the role of inflammation in cardiovascular and other diseases, ... an inflammatory response in the body -- and the genes ... in the journal Proceedings of the National Academy of ... (HuR) plays a critical role in inducing and mediating an ...
... ) today announced that its board of directors has declared a first quarter 2010 dividend of $0.14 per share of common stock.  The dividend is equivalent to an annualized dividend ... ... ... ...
Cached Biology Technology:Kinexus Announces the Launch of New Peptide Production Services 2Researchers identify a gene that may play a key role in atherosclerosis and other diseases 2Researchers identify a gene that may play a key role in atherosclerosis and other diseases 3BioMed Realty Trust Declares First Quarter 2010 Common Stock and Preferred Stock Dividends 2BioMed Realty Trust Declares First Quarter 2010 Common Stock and Preferred Stock Dividends 3
... 10 L sample. Ideal for small volume applications, including pediatric, neonatal, geriatric, general adult, veterinary and ... than 3 minutes after turn-on. ... ... ...
Red Standard is sodium salt of resorufin....
APG5 autophagy 5-like (S. cerevisiae)...
...
Biology Products: